US Patent No: 8,092,831
Number of patents in Portfolio can not be more than 2000
Antihistamine and decongestant system
Stats
-
Jan 10, 2012
Issued date -
Nov 8, 2002
filing date -
10/291,103
serial no -
In Force
status
Importance
Loading Importance Indicators...
Abstract
The present invention relates to an oral pharmaceutical formulation that employs: (1) a compressed core containing a decongestant or pharmaceutically acceptable salt thereof; (2) a delayed release coating on the compressed core and (3) immediate release therapeutic amounts of a decongestant and an antihistamine.
Loading the Abstract Image...
First Claim
Related Publications
Loading Related Publications...
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art
| Patent Info | (Count) | # Cites | Year |
|---|---|---|---|
|
|
|||
| 5,004,613 Oral sustained release pharmaceutical formulation and process | 30 | 1989 | |
| 5,073,380 Oral sustained release pharmaceutical formulation and process | 27 | 1990 | |
| 5,215,755 Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets | 36 | 1991 | |
| 5,658,589 Subcoated simulated capsule-like medicament | 25 | 1991 | |
| 5,405,617 Aliphatic or fatty acid esters as a solventless carrier for pharmaceuticals | 12 | 1991 | |
| 5,272,137 Aqueous pharmaceutical suspension for pharmaceutical actives | 41 | 1992 | |
| 5,429,825 Rotomelt granulation | 23 | 1992 | |
| 5,296,233 Dual subcoated simulated capsule-like medicament | 24 | 1992 | |
| 5,451,409 Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends | 33 | 1993 | |
| 5,489,436 Taste mask coatings for preparation of chewable pharmaceutical tablets | 66 | 1993 | |
| 5,409,907 Aqueous pharmaceutical suspension for pharmaceutical actives | 37 | 1993 | |
| 5,529,783 Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally dextromethorphan | 15 | 1994 | |
| 5,681,577 Multiple action cold/sinus preparations | 14 | 1995 | |
| 5,919,481 Fill material for soft gelatin pharmaceutical dosage form | 7 | 1996 | |
| 5,658,919 Aqueous pharmaceutical suspension and process for preparation thereof | 18 | 1996 | |
| 5,916,590 Soft gelatin pharmaceutical dosage form | 9 | 1996 | |
| 5,876,759 Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof | 37 | 1997 | |
| 5,840,337 Gelling agent for polyethylene gylcol | 3 | 1997 | |
| 5,891,476 Tastemasked pharmaceutical system | 15 | 1997 | |
|
|
|||
| 4,282,233 Antihistaminic 11-(4-piperidylidene)-5H-benzo-[5,6]-cyclohepta-[1,2-b]-pyridines | 100 | 1980 | |
| 4,695,591 Controlled release dosage forms comprising hydroxypropylmethylcellulose | 40 | 1985 | |
| 4,659,716 Antihistaminic 8-(halo)-substituted 6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridines | 53 | 1986 | |
| 4,999,189 Sustained release oral suspensions | 28 | 1988 | |
| 4,990,535 Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine | 51 | 1989 | |
| 5,100,675 Sustained release tablet comprising loratadine, ibuprofen and pseudoephedrine | 49 | 1990 | |
| 5,869,479 Treatment of upper airway allergic responses | 57 | 1997 | |
| 6,114,346 Treating sleep disorders using desloratadine | 14 | 1999 | |
|
|
|||
| 5,431,916 Pharmaceutical compositions and process of manufacture thereof | 37 | 1993 | |
| 5,510,389 Concentrated acetaminophen solution compositions | 3 | 1994 | |
| 5,827,852 Coated pharmaceutical compositions | 20 | 1994 | |
| 5,458,879 Oral vehicle compositions | 57 | 1994 | |
| 5,560,913 Pharmaceutical compositions | 12 | 1995 | |
| 5,641,512 Soft gelatin capsule compositions | 25 | 1995 | |
| 5,560,921 Chewable decongestant compositions | 3 | 1995 | |
| 5,648,358 Compositions and methods for treating respiratory disorders | 6 | 1996 | |
|
|
|||
| 4,749,711 Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs | 16 | 1987 | |
| 4,749,721 Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs | 17 | 1987 | |
| 4,749,722 Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs | 18 | 1987 | |
| 4,839,354 Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs | 17 | 1987 | |
| 5,025,019 Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs | 17 | 1989 | |
|
|
|||
| 4,801,461 Pseudoephedrine dosage form | 28 | 1987 | |
| 4,915,952 Composition comprising drug, HPC, HPMC and PEO | 14 | 1989 | |
| 4,915,953 Dosage form for delivering acetaminophen or phenylpropanolamine | 43 | 1989 | |
| 5,023,076 Lamina comprising carboxyvinyl polymer | 6 | 1990 | |
|
|
|||
| 5,024,997 Palatable ibuprofen solutions | 15 | 1990 | |
| 5,616,621 Taste masking liquids | 6 | 1995 | |
| 5,602,182 Taste masking pseudoephedrine HCL containing liquids | 10 | 1995 | |
| 5,759,579 Pharmaceutical suspension systems | 30 | 1996 | |
|
|
|||
| 4,632,821 Magnesium trisilicate suitable for preparation of medicament adsorbates of decongestants | 19 | 1985 | |
| 4,758,424 Medicament adsorbates of decongestants with complex magnesium aluminum silicate and their preparation | 38 | 1987 | |
| 5,385,941 Salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms | 9 | 1993 | |
|
|
|||
| 5,654,005 Controlled release formulation having a preformed passageway | 34 | 1995 | |
| 5,922,352 Once daily calcium channel blocker tablet having a delayed release core | 15 | 1997 | |
|
|
|||
| 4,999,226 Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination | 19 | 1989 | |
| 4,996,061 Pharmaceutical composition for piperidinoalkanol-decongestant combination | 32 | 1989 | |
|
|
|||
| 5,876,752 Use of interfacially-polymerized membranes in delivery devices | 12 | 1993 | |
| 5,698,220 Asymmetric membranes in delivery devices | 27 | 1995 | |
|
|
|||
| 2003/0035,839 Pharmaceutical composition for both intraoral and oral administration | 11 | 2001 | |
| 6,827,946 Compositions containing both sedative and non-sedative antihistamines | 3 | 2001 | |
|
|
|||
| 4,792,452 Controlled release formulation | 87 | 1987 | |
| 5,169,638 Buoyant controlled release powder formulation | 75 | 1991 | |
|
|
|||
| 4,800,087 Taste-masked pharmaceutical compositions | 89 | 1986 | |
| 5,084,278 Taste-masked pharmaceutical compositions | 88 | 1989 | |
|
|
|||
| 4,996,047 Sustained release drug-resin complexes | 58 | 1988 | |
| 5,141,961 Process for solubilizing difficulty soluble pharmaceutical actives | 17 | 1991 | |
|
|
|||
| 5,518,730 Biodegradable controlled release flash flow melt-spun delivery system | 144 | 1992 | |
| 5,869,098 Fast-dissolving comestible units formed under high-speed/high-pressure conditions | 48 | 1997 | |
|
|
|||
| 4,552,899 Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs | 51 | 1984 | |
|
|
|||
| 5,837,379 Once daily pharmaceutical tablet having a unitary core | 37 | 1997 | |
|
|
|||
| 5,763,449 Pleasant-tasting aqueous liquid composition of a bitter-tasting drug | 11 | 1996 | |
|
|
|||
| 5,691,370 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2-adrenoceptor agonists | 12 | 1996 | |
|
|
|||
| 4,952,402 Controlled release powder and process for its preparation | 155 | 1988 | |
|
|
|||
| 4,959,219 Coating barriers comprising ethyl cellulose | 16 | 1988 | |
|
|
|||
| 4,369,172 Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose | 210 | 1981 | |
|
|
|||
| 5,834,019 Pharmaceutical formulation containing a hydrophobic active substance and an effervescent system | 7 | 1996 | |
|
|
|||
| 5,660,833 Anti-tussive composition | 3 | 1996 | |
|
|
|||
| 5,466,865 Neomorphic ibuprofen and methods of using same | 3 | 1993 | |
|
|
|||
| 5,663,415 Process for preparing antihistamine tannates | 31 | 1996 | |
|
|
|||
| 5,795,574 Use of an extract from a non-photosynthetic filamentous bacterium and composition containing it | 16 | 1996 | |
|
|
|||
| 5,807,579 Pseudoephedrine combination pharmaceutical compositions | 37 | 1996 | |
|
|
|||
| 4,762,709 Liquid prolonged release pharmaceutical formulations containing ionic constituents | 23 | 1986 | |
|
|
|||
| 4,650,807 Antihistaminic compositions and methods containing pyridine derivatives | 8 | 1985 | |
|
|
|||
| 4,692,462 Compositions and method of controlling transdermal penetration of topical and systemic agents | 25 | 1985 | |
|
|
|||
| 5,314,697 Stable extended release oral dosage composition comprising loratadine and pseudoephedrine | 37 | 1992 | |
|
|
|||
| 5,662,936 Sugar-coated pharmaceutical dosage unit | 5 | 1994 | |
|
|
|||
| 5,895,663 Pseudoephedrine hydrochloride extended-release tablets | 12 | 1997 | |
|
|
|||
| 4,834,985 Controlled release pharmaceutical composition | 160 | 1987 | |
|
|
|||
| 5,858,409 Hydrolyzed cellulose granulations for pharmaceuticals | 35 | 1996 | |
|
|
|||
| 6,267,986 Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine | 9 | 1999 | |
|
|
|||
| 4,576,645 Whipped gel composition | 19 | 1984 | |
|
|
|||
| 5,288,503 Cryogel oral pharmaceutical composition containing therapeutic agent | 71 | 1992 | |
|
|
|||
| 4,181,719 Analgesic N-acetyl-para-aminophenyl N'-acetylaminothioalkanoates | 11 | 1978 | |
|
|
|||
| 5,881,926 Pharmaceutical compositions in semisolid form and a device for administration thereof | 25 | 1993 | |
|
|
|||
| 5,126,145 Controlled release tablet containing water soluble medicament | 96 | 1990 | |
|
|
|||
| 5,595,997 Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine | 30 | 1994 | |
|
|
|||
| 4,777,170 Method to prevent and treat the signs and symptoms of motion sickness | 22 | 1987 | |
| 5,543,405 Composition and method for weight reduction and long term management of obesity | 36 | 1994 | |
| 5,859,060 Timed release tablet comprising naproxen and pseudoepherine | 23 | 1997 | |
Patent Citation Ranking
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 3.5 Year Payment | $1600.00 | $800.00 | $400.00 | Jul 10, 2015 |
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Jul 10, 2019 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Jul 10, 2023 |
| Fee | Large entity fee | small entity fee | micro entity fee |
|---|---|---|---|
| Surcharge - 3.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
| Surcharge - 7.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
| Surcharge - 11.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
| Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
| Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |